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Inflammatory bowel disease is associated with an increased risk of mental disorders and
can be exacerbated by stress. In this study which was performed with male 10-week
old C57Bl/6N mice, we used dextran sulfate sodium (DSS)-induced colitis to evaluate
behavioral changes caused by intestinal inflammation, to assess the interaction between
repeated psychological stress (water avoidance stress, WAS) and colitis in modifying
behavior, and to analyze neurochemical correlates of this interaction. A 7-day treatment
with DSS (2% in drinking water) decreased locomotion and enhanced anxiety-like behavior
in the open field test and reduced social interaction. Repeated exposure to WAS
for 7 days had little influence on behavior but prevented the DSS-induced behavioral
disturbances in the open field and SI tests. In contrast, repeated WAS did not modify
colon length, colonic myeloperoxidase content and circulating proinflammatory cytokines,
parameters used to assess colitis severity. DSS-induced colitis was associated with
an increase in circulating neuropeptide Y (NPY), a rise in the hypothalamic expression
of cyclooxygenase-2 mRNA and a decrease in the hippocampal expression of NPY
mRNA, brain-derived neurotrophic factor mRNA and mineralocorticoid receptor mRNA.
Repeated WAS significantly decreased the relative expression of corticotropin-releasing
factor mRNA in the hippocampus. The effect of repeated WAS to blunt the DSS-evoked
behavioral disturbances was associated with a rise of circulating corticosterone and
an increase in the expression of hypothalamic NPY mRNA. These results show that
experimental colitis leads to a particular range of behavioral alterations which can be
prevented by repeated WAS, a model of predictable chronic stress, while the severity
of colitis remains unabated. We conclude that the mechanisms underlying the resilience
effect of repeated WAS involves hypothalamic NPY and the hypothalamic-pituitary-adrenal
axis.
Keywords: DSS-induced colitis, resilience, anxiety, social interaction, cyclooxygenase 2, neuropeptide Y,
corticosterone, gut-brain axis
INTRODUCTION
Inflammatory bowel disease (IBD) is a major health problem
mainly in the Western countries where the prevalence of IBD
is more than 200 per 100,000 inhabitants (Cosnes et al., 2011).
The disease reduces quality of life, and the deterioration of well-
being is exacerbated in the presence of psychiatric disturbances
(Guthrie et al., 2002; Nordin et al., 2002). Several mental disor-
ders including major depression, panic and generalized anxiety
are more common in IBD patients than in community controls
(Walker et al., 2008; Graff et al., 2009). Moreover, psychiatric dis-
orders can affect disease prognosis and response to treatment.
For example, infliximab is less efficacious in Crohns’ disease
patients with major depression than in non-depressed Crohn’s
disease subjects (Persoons et al., 2005). The relationship between
IBD and changes in the brain is emphasized by epidemiological
studies showing that stressful life events can be a risk factor for
IBD development and relapse (Mawdsley and Rampton, 2006).
The continuously accumulating evidence that connects IBD with
psychiatric disorders underscores the necessity to study brain
reactions to gastrointestinal inflammation.
Adding dextran sulfate sodium (DSS) to rodents’ drinking
water leads to the development of colitis. Showing many simi-
larities to human IBD pathology, DSS-induced colitis is widely
perceived as a model of IBD with good translational power
(Solomon et al., 2010). Inspired by human data, the effect of
psychological stress has repeatedly been tested in the DSS model
of IBD and in most studies found to aggravate the severity of
inflammation (Milde and Murison, 2002; Reber et al., 2006).
Moreover, mice with DSS-induced colitis have been reported to
exhibit anxiety-like behavior (Bercik et al., 2011; Painsipp et al.,
2011), but the neurochemical basis of these behavioral alterations
has not yet been addressed.
The molecular basis of behavioral changes associated with
DSS-induced colitis has not yet been elucidated. Studies of other
peripheral immune challenge models suggest that a concurrent
inflammatory process in the brain may play a role. Peripheral
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injection of lipopolysaccharide (LPS) is associated with increased
expression of cyclooxygenase 2 (COX-2), but not COX-1, in
the hypothalamus (Cover et al., 2001). COX-2 and one of its
products, prostaglandin E2, have been involved in LPS- and inter-
leukin (IL)1β-induced anorexia which is inhibited by COX-2
but not COX-1 inhibitors (Lugarini et al., 2002; Asarian and
Langhans, 2010). These findings raise the question whether COX-
2 participates in the behavioral changes caused by DSS-induced
colitis.
Psychological stress is a risk factor for several psychiatric
disturbances. Stressful life events precede episodes of several men-
tal disorders including generalized anxiety disorder and major
depression (Blazer et al., 1987; Kendler et al., 2003). Water
avoidance stress (WAS) is a model of psychological stress in
rodents, in which animals are placed on a platform surrounded
by water which prevents them from escaping. WAS efficiently
stimulates stress-related circuits in the brain in rats and mice,
and repeated exposure to WAS leads to anxiety-like behav-
ior and visceral hyperalgesia in rats (Bonaz and Taché, 1994;
Bradesi et al., 2005; Reichmann et al., 2013; Ait-Belgnaoui et al.,
2014). However, repeated psychological stress can lead to a wide
range of behavioral manifestations, occasionally being without
effect (Gregus et al., 2005) or even improving behavioral per-
formance. For example, 5-min sessions of restraint stress for 28
days improve mood, hippocampal neurogenesis, and cognitive
function in rats (Parihar et al., 2011). Moreover, if applied in
adolescence, the same stress protocol induces resilience against
chronic unpredictable stress in adulthood (Suo et al., 2013).
Despite the extensive literature that evaluated the influence of
psychological stress on chemically induced colitis, very little
is known about the effect of psychological stress on colitis-
associated behavioral and molecular changes and whether or
not psychological stress impacts on DSS-induced behavioral
alterations.
The objective of this work, therefore, was to evaluate the
interaction between repeated psychological stress (WAS) and
DSS-induced colitis in modifying emotional-affective behavior
and to analyze potential mechanisms behind this interaction.
The study set out to address four specific aims. The first aim
was to evaluate whether DSS-induced colitis in C57Bl6/N mice
is associated with anxiety-like behavior, social isolation, and
despair behavior. The second aim was to assess whether com-
bining WAS with DSS would influence DSS-induced colitis and
DSS-induced behavioral changes in a similar or differential man-
ner. The third aim was to examine whether colonic inflamma-
tion extended to the brain by evaluating gene expression of
cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) in
the brain. Finally, the fourth aim was to explore the mecha-
nistic basis of the interaction between stress and inflammation
on brain function and behavior. This goal was addressed by
investigating the plasma level of corticosterone and the cerebral
expression of corticotropin-releasing factor (CRF), mineralo-
corticoid receptors (MR) and glucocorticoid receptors (GR) as
important factors of the hypothalamic-pituitary-adrenal (HPA)
axis and brain-derived neurotrophic factor (BDNF) and neu-
ropeptide Y (NPY) as messengers relevant to emotional-affective
behavior.
MATERIAL AND METHODS
EXPERIMENTAL ANIMALS
The experiments were carried out with male C57BL/6N mice
obtained from Charles River (Sulzfeld, Germany) at the age
of 10 weeks. The animals were housed two per cage under
controlled conditions of temperature (set point 21◦C) and air
humidity (set point 50%) and under a 12 h light/dark cycle
(lights on at 6:00 h, lights off at 18:00 h). Standard laboratory
chow was provided ad libitum throughout the study. The mice
were habituated in the animal facility for 2 weeks before any
intervention. All experiments were approved by an ethical com-
mittee at the Federal Ministry of Science, Research and Economy
of the Republic of Austria (BMWF-66.010/0118-II/3b/2011 and
BMWFW-66.010/0054-WF/II/3b/2014) and conducted accord-
ing to the Directive of the European Communities Council
of 24 November 1986 (86/609/EEC) and the Directive of the
European Parliament and of the Council of 22 September 2010
(2010/63/EU). The experiments were designed in such a way
that both the number of animals used and their suffering was
minimized.
STUDY DESIGN
In order to investigate the interaction between DSS-induced col-
itis and repeated WAS on behavioral changes, 68 mice were
allocated to 4 experimental groups:
(1) a control group (n = 16), handled once daily from day 1 to
day 7,
(2) the water avoidance stress (WAS) group (n = 16), exposed to
intermittent WAS once daily for 1 h from day 1 to day 7,
(3) the DSS colitis group (n = 18), receiving DSS (2%) in the
drinking water and handled once daily from day 1 to day 7,
and
(4) the WAS+DSS group (n = 18), subjected to both WAS and
DSS treatment from day 1 to day 7.
In study 1, the effect of a 7-day treatment with WAS, DSS, and
WAS+DSS on the behavior of the animals was evaluated. Body
weight was measured on day 1 and day 8. Anxiety-like behavior
and locomotor activity were assessed with the open (OF) field test
on day 8. On day 9, social activity was evaluated with the social
interaction (SI) test. On day 10, depression-like behavior was
evaluated with the tail suspension test (TST). On day 11 the mice
were sacrificed by decapitation after they had been deeply anes-
thetized with pentobarbital (150mg/kg IP) to collect the colon
for myeloperoxidase (MPO) determination.
In study 2, the effect of a 7-day treatment with WAS, DSS, and
WAS+DSS on molecular factors in the colon, blood, and brain
was assessed in the absence of any behavioral tests. In this study
the daily food and daily water intake were assessed by weighing
the food pellets and the water bottles of the housing cages at the
beginning of the WAS session. On day 8, the animals were sac-
rificed as described, and plasma, colon and brain collected. The
total number of mice used in study 2 was 32 (n = 8 per group).
In both studies, all behavioral tests, plasma and tissue
collections were carried out between 8:00 and 13:00 h.
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INDUCTION OF COLITIS
Mild colitis was induced by adding DSS (molecular weight
36,000–50,000; MP Biomedicals, Illkirch, France) at a concentra-
tion of 2% (w/v) to the drinking water for 7 days (Mitrovic et al.,
2010). Control animals received normal tap water.
WATER AVOIDANCE STRESS
Mice were placed on a small platform (6 × 3 × 3 cm, length ×
width × height) in the center of a water-filled tank (50 × 32 ×
30 cm, length×width× height), the level of the water in the tank
being 0.5–1 cm below the platform. After a 60min stay on the
platform the animals were returned to their home cages (Melgar
et al., 2008). The mice were not pre-trained to avoid jumping
into the water. During the WAS session the mice were surveyed
by an investigator. If mice jumped into the water, the investigator
put them back immediately on the platform. It was observed that
mice tried to escape more frequently in the first 2 days of the 7-
day treatment period, whereas in the remaining 5 days the trials
to escape were uncommon. The WAS procedure was carried out
between 10:00 and 13:00 h. Each individual mouse was exposed
to WAS every day at the same time of the day that did not vary
more than 30min.
OPEN FIELD TEST
The OF consisted of an opaque gray plastic box (50× 50× 50 cm,
length×width× height). The ground area of the box was divided
into a 36 × 36 cm central area and the surrounding border zone.
The mice were placed individually in a corner of the OF, and their
behavior during a 5min test period was tracked by a video camera
positioned above the center of the OF and recorded with the soft-
ware VideoMot2 (TSE Systems, Bad Homburg, Germany). This
software was used to evaluate the time spent in the central area,
the number of entries into the central area, the total distance trav-
eled in the OF, and the distance traveled in the central area. A
reduction of the central area time, of the distance traveled in the
central area, and/or of the central area entries was interpreted as
an increase in anxiety-like behavior (Bailey and Crawley, 2009).
The OF box was cleaned with water after each mouse had been
tested.
SOCIAL INTERACTION TEST
The SI test was performed in the OF box as described (Tabuchi
et al., 2007; de Theije et al., 2014). An empty cylindrical mesh-
work container (7 × 10 cm, diameter × height) was placed
adjacent to the middle of one wall of the OF. The test mouse
was placed adjacent to the middle of the opposite wall of the
OF and allowed to explore the field for 3min, after which the
mouse was returned to its home cage. A novel mouse (target
mouse) was placed in the cylindrical container, and then the
test mouse was allowed to explore the OF for another 3min.
The time spent in the interaction zone which was within 8 cm
of the cylindrical container was calculated with the VideoMot2
software in both sessions. Social activity was expressed as SI
percent which was defined as the percent ratio between the
time spent in the interaction zone in the presence of the tar-
get mouse divided by the time spent in the interaction zone in
the absence of the target mouse. The OF box was cleaned with
70% ethanol after each mouse had been tested (de Theije et al.,
2014).
TAIL SUSPENSION TEST
The animals were suspended by their tail with a 1.9 cm wide
strapping tape (Leukotape classic, BSN Medical S.A.S., Le Mans,
France) for 6min, and their behavior was recorded by a video
camera. A trained blinded observer analyzed the video record-
ings with the VideoMot2 software event monitoring module
for 3 types of behavior: swinging, curling and immobility. The
mouse was considered swinging when it continuously moved
its paws while keeping the body straight and/or moving the
body from side to side. The mouse was considered curling
when the mouse twisted its trunk (Berrocoso et al., 2013).
The time spent swinging, curling and being immobile was cal-
culated. Mice which climbed over their tails were excluded
as they had learned that escape is possible (Cryan et al.,
2005).
COLLECTION OF BLOOD AND TISSUES
Blood was collected by cardiac puncture with 3.8% citrate as
anticoagulant during sacrifice within 3.5min after injection of
pentobarbital. After centrifugation at 1600 × g for 15min at
4◦C, the plasma was frozen immediately on dry ice and stored
at −70◦C until assay.
Colon length and colon weight were used to assess colitis sever-
ity (Vowinkel et al., 2004). After decapitation of the mice, the
colon extending from the proximal end at the cecum to the anal
end was rapidly removed and its length measured. Subsequently
the colon was opened longitudinally, washed under running
water, dried with tissue paper, and its weight (mg) determined.
Then the distal part of the colon was shock-frozen in liquid
nitrogen and stored at −70◦C until MPO assay. The brains were
removed, frozen on dry ice, wrapped in aluminum foil, and stored
at −70◦C.
COLONIC MYELOPEROXIDASE MEASUREMENT
MPO is an enzyme found mainly in neutrophils, monocytes
and macrophages and has frequently been used to quan-
tify experimental colitis severity (Krawisz et al., 1984). The
MPO content of the colon was measured with an enzyme-
linked immunosorbent assay kit specific for the rat and
mouse protein (Hycult Biotechnology, Uden, The Netherlands).
The tissue samples were prepared according to the manufac-
turer’s instructions. After weighing, the frozen tissues were
placed in MPO lysis buffer (pH 7.4) at a ratio of 1 mg:
0.02ml. The composition of the lysis buffer was: 200mM
NaCl, 5mM ethylenediaminetetraacetic acid, 10mM trishy-
droxy methylaminomethane, 10% glycerine, 1mM phenyl-
methylsulphonyl fluoride, 1mg/ml leupeptide, and 28mg/ml
aprotinin.
The samples were homogenized on ice with an Ultraturrax
(IKA, Staufen, Germany) and then subjected to two centrifuga-
tion steps at 6000 × g and 4◦C for 15min. The MPO content
of the supernatant was measured with the kit. The sensitivity of
the assay was 1 ng/ml at an intra- and inter-assay variation of
around 10%.
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MULTIPLEX MEASUREMENT OF PLASMA CYTOKINES
The plasma levels of IL-6, IL-10, IL-12, and IL-18 were
measured with amultiplex immunoassay (ProcartaPlexMultiplex
Immunoassays, eBioscience, Vienna, Austria). The assay was
performed according to the manufacturer’s instructions. The
fluorescent signal was measured with the Bio-Plex 200 mul-
tiplex suspension array system in combination with the Bio-
Plex 5.0 Software (Bio-Rad, Hercules, CA, USA). Standard
curves were generated with a five-parameter logistic curve-
fitting method. Cytokines that were below detection limit were
assigned a value of zero. The sensitivities of the assay were 0.9,
0.35, 0.35, and 8.09 pg/ml for IL-6, IL-10, IL-12, and IL-18,
respectively.
PLASMA NEUROPEPTIDE Y (NPY) AND CORTICOSTERONE
MEASUREMENTS
The plasma levels of NPY and corticosterone were determined
with specific enzyme immunoassay kits according to the manu-
facturer’s instructions. The sensitivity of the NPY kit (Phoenix
Pharmaceuticals, Burlingame, CA, USA) was 0.09 ng/ml, while
the sensitivity of the corticosterone kit (Assay Designs, Ann
Arbor, MI, USA) was 0.027 ng/ml.
BRAIN MICRODISSECTION
For the microdissection procedure, the frozen brains were trans-
ferred to a cryostat at −20◦C and cut manually into approxi-
mately 1mm thick slices. These brain slices were placed on a
cold plate (Weinkauf Medizintechnik, Forchheim, Germany) set
at −20◦C, on which hypothalamus, amygdale, and hippocampus
weremicrodissected under a stereomicroscope. Hypothalamic tis-
sue was collected from the preoptic area (Bregma: +0.26) to the
end of the mammillary bodies (Bregma: −2.92), amygdalar tis-
sue from the anterior edge of the optical tract (Bregma: −0.58)
to the posterior part of the basolateral and basomedial amygdala
(Bregma: −2.54), and hippocampal tissue from the limit of the
hippocampal formation (Bregma: −0.94) to the caudal end of the
dentate gyrus (Bregma: −4.04). The microdissected brain areas
were kept in homogenization tubes on dry ice and subsequently
stored at −70◦C until further processing (Brunner et al., 2014).
RNA EXTRACTION AND REAL TIME PCR
RNA was extracted from the microdissected brain regions with
the RNeasy Lipid Tissue Mini Kit (Qiagen, Hilden, Germany).
Aliquots of 1μg RNA were reverse-transcribed with the High
Capacity cDNA Reverse Transcription kit (Applied Biosystems,
Foster City, CA, USA).
For relative quantification of mRNA, real time PCR was per-
formed with the CFXConnect™Real-Time PCR detection system
in combination with the CFX Manager™ software 3.1 (Bio-Rad).
The specific primers used for amplification and quantitation
of mRNA are listed in Table 1. GAPDH (Mm_Gapdh_3_SG
QuantiTect Primer Assay, Qiagen) was used as reference gene.
The stability of GAPDH as a reference gene was confirmed
with theM value (Vandesompele et al., 2002; Hellemans et al.,
2007) as assessed by the CFX Manager™ 3.1 software. The PCR
SsoAdvanced™ Universal SYBR® Green Supermix (Bio-Rad) was
used for amplification, and the cycling conditions were as follows:
Table 1 | Primers used in the study.
Gene Primer sequence (5′→3′) References
BDNF forward GTGACAGTATTAGCGAGTGG Designed by
Primer-Blast (Ye et al.,
2012)
BDNF reverse TTCTCTAGGACTGTGACCGT
COX-1 forward ATGAGTCGAAGGAGTCTCTCG Harvard PrimerBank
(Spandidos et al.,
2010) ID: 6679537a1
COX-1 reverse GCACGGATAGTAACAACAGGGA
COX-2 forward TTCAACACACTCTATCACTGGC Harvard PrimerBank
ID: 31127110a1
COX-2 reverse AGAAGCGTTTGCGGTACTCAT
CRF forward GAATTTCTTGCAGCCGGAGC Designed by
Primer-Blast
CRF reverse CAGCGGGACTTCTGTTGAGA
GR forward GACTCCAAAGAATCCTTAGCTCC Harvard PrimerBank
ID: 121247452c1
GR reverse CTCCACCCCTCAGGGTTTTAT
MR forward GAAGAGCCCCTCTGTTTGCAG Harvard PrimerBank
ID: 17384011a1
MR reverse TCCTTGAGTGATGGGACTGTG
NPY forward CAGATACTACTCCGCTCTGCGAC
ACTACAT
Ferenczi et al., 2010
NPY reverse TTCCTTCATTAAGAGGTCTGAAAT
CAGTGTCT
samples were heated to 95◦C for 30 s followed by 39 cycles of 95◦C
for 3 s, and 60◦C for 30 s. Except for the GAPDH primers which
have been validated by the manufacturer, the products of all other
primers were sequenced to confirm specificity. Quantitative val-
ues of mRNA relative to control were calculated with the 2−CT
method (Schmittgen and Livak, 2008).
STATISTICS
SPSS 21 and SigmaPlot 12.1 were used for statistical analysis and
graphic presentation of the results. The data were analyzed with
Two-Way ANOVA, one factor being DSS treatment, and the other
factor being WAS. Log transformation was considered whenever
needed to meet Two-Way ANOVA assumptions. For the analysis
of colonic MPO levels ANOVA was performed after rank trans-
formation. Whenever a significant interaction between WAS and
DSS was found, a Bonferroni post-hoc test was carried out. Main
factor effects and interactions between the two factors were con-
sidered significant if p ≤ 0.05. Daily food and water intake was
evaluated with repeated measures ANOVA. Sphericity assump-
tions were checked by Mauchly’s test and, in case of violation
of sphericity, the Greenhouse-Geisser correction was used. Since
the levels of proinflammatory cytokines did not meet Two-Way
ANOVA assumptions, the Kruskal-Wallis test was employed and
post-hoc theMann-Witney U test with Bonferroni correction was
used for pairwise comparisons.
RESULTS
WAS HAD NO MAJOR EFFECT ON THE SEVERITY OF DSS-INDUCED
COLITIS
Treatment with 2% DSS induced colitis, the severity of which
was assessed by animal weight, colon length, colon weight
(Tables 2, 3), and colonic MPO levels (Figure 1). As shown in
Tables 2, 3, DSS treatment caused body weight loss, increased
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Table 2 | Effect of DSS and WAS, alone and in combination on body weight loss, colon weight, and colon length in mice that underwent
behavioral tests.
Control WAS DSS WAS + DSS WAS main DSS main Interaction
n = 16 n = 16 n = 18 n = 18 factor effect factor effect
Body weight change (g) on day 8 +0.31 (0.18) −0.06 (0.28) −1.39 (0.22) −1.83 (0.28) NS p < 0.001 NS
Colon weight (mg/cm) on day 11 29.9 (0.86) 31.7 (0.97) 49.6 (1.99) 47.7 (1.54) NS p < 0.001 NS
Colon length (cm) on day 11 7.80 (0.19) 7.63 (0.13) 5.81 (0.15) 5.51 (0.14) NS p < 0.001 NS
The mice were sacrificed 4 days after the end of treatment with DSS and WAS.
Animals were subjected to a 7-day treatment (days 1–7) with DSS (2% in the drinking water) and WAS (1 h daily), alone or in combination, followed by behavioral
testing during days 8–10. The mice were sacrificed on day 11, i.e., 4 days after the end of treatment with DSS and WAS. The data are presented as means (s.e.m.).
NS, not significant.
Table 3 | Effect of DSS and WAS, alone and in combination, on body weight loss, colon weight, and colon length in mice used for the assay of
biochemical factors in the colon, blood and brain in the absence of any behavioral testing.
Control WAS DSS WAS + DSS WAS main DSS main Interaction
n = 8 n = 8 n = 8 n = 8 factor effect factor effect
Body weight change (g) on day 8 +0.64 (0.17) +0.02 (0.17) −2.47 (0.29) −3.90 (0.57) p < 0.01 p < 0.001 NS
Colon weight (mg/cm) on day 8 30.9 (1.49) 28.6 (0.76) 41.7 (1.71)*** 46.7 (1.87)§### NS p < 0.001 p < 0.05
Colon length (cm) on day 8 8.65 (0.35) 8.75 (0.27) 6.51 (0.40) 5.95 (0.30) NS p < 0.001 NS
The mice were sacrificed 1 day after the end of treatment with DSS and WAS.
Animals were subjected to a 7-day treatment (days 1–7) with DSS (2% in the drinking water) and WAS (1 h daily), alone or in combination, and sacrificed for the
assay of biochemical factors in the colon, blood and brain on day 8, i.e., 1 day after the end of treatment with DSS and WAS. The data are presented as means
(s.e.m.). ***p < 0.001 vs. control (colon weight), §p < 0.05 vs. DSS (colon weight), ###p < 0.001 vs. WAS (colon weight). NS, not significant.
FIGURE 1 | Colonic MPO content in mice subjected to a 7-day treatment
with WAS, DSS, or WAS+DSS (n = 15–18 per group) followed by
behavioral testing during days 8–10 as carried out in study 1 (A) or
sacrificed on day 8 (n = 8 per group) without behavioral testing as
examined in study 2 (B). In both studies Two-Way ANOVA disclosed a
significant DSS effect (p < 0.001) but no WAS effect and no significant
interaction. The data shown are means + s.e.m., χχχp < 0.001 DSS main
factor effect.
colon weight and reduced colon length. These changes were also
seen in animals treated with WAS+DSS but were absent in mice
treated with WAS alone. Two-Way ANOVA in the animals sub-
jected to behavioral tests (study 1, Table 2) revealed a significant
main factor effect of DSS treatment on weight loss [F(1, 64) =
55.7; p < 0.001], colon weight [F(1, 64) = 148.2; p < 0.001], and
colon length [F(1, 64) = 182.3; p < 0.001]. In none of the exper-
imental groups was there any significant interaction between the
factors WAS and DSS (Table 2). In addition, DSS treatment led to
a significant rise of the colonic MPO content [main factor effect:
F(1, 62) = 187; p < 0.001] while WAS had no significant effect
and there was no significant interaction between WAS and DSS
(Figure 1A).
In the animals that were used for the assay of biochemical fac-
tors in the colon, blood and brain in the absence of any behavioral
testing (study 2), DSS had a similar effect as in study 1 (com-
pare Tables 2, 3). Two-Way ANOVA showed a significant main
factor effect of DSS on body weight loss [F(1, 28) = 106.8; p <
0.001], and colon length [F(1, 28) = 54.7; p < 0.001]. A signif-
icant main factor effect of WAS was observed only with body
weight loss [F(1, 28) = 9.2; p = 0.005], and a significant interac-
tion between the factors WAS and DSS was disclosed for colon
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weight only [F(1, 28) = 5.7; p = 0.024]. Post-hoc analysis revealed
that DSS significantly increased colon weight, an effect that was
exacerbated by WAS while WAS alone did not affect colon weight
(Table 3). The colonic MPO content was significantly elevated
by DSS [main factor effect: F(1, 28) = 86.7; p < 0.001] but not
WAS, without any significant interaction between the two factors
(Figure 1B).
DSS, BUT NOT WAS, REDUCED THE DAILY FOOD INTAKE
The cumulative water intake over the 7-day treatment period
was not significantly changed in response to the WAS and DSS
treatments (Figure 2A). Repeated measures ANOVA (Figure 2C),
however, showed a significant change of the daily water
intake during the 7-day treatment period [F(6, 13) = 13.1;
p < 0.001], with a significant interaction with DSS [F(6, 13) =
FIGURE 2 | Effect of a 7-day treatment with DSS and WAS, alone and
in combination, on water and food intake as examined in study 2.
(A) Cumulative water intake over the 7-day treatment period. There were
no significant differences. (B) Cumulative food intake over the 7-day
treatment period. There was a significant main factor effect of DSS on
total food intake (p < 0.001). (C) Daily water consumption during the
7-day treatment period. Repeated measures ANOVA disclosed that DSS
significantly modified the daily water intake during the 7-day observation
period. Post-hoc testing showed a significant main factor effect of DSS
on days 3 and 6 (p < 0.05). (D) Daily food consumption during the 7-day
treatment period. Repeated measures ANOVA revealed that DSS
significantly suppressed the daily water intake. Post-hoc testing showed
a significant main factor effect of DSS during days 5–7 (p < 0.001). The
data shown are means + s.e.m. (A,B) and means ± s.e.m. (C,D), n = 4
cages per group each housing two mice, χp < 0.05 DSS main factor
effect, χχχp < 0.001 DSS main factor effect.
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11.1; p < 0.001] but not WAS. In the DSS-treated mice, the daily
water intake was enhanced during days 1–4 but this difference was
statistically significant only on day 3 (Figure 2C). Subsequently,
the daily water intake dropped below the daily water intake of
control mice, this difference being statistically significant on day
6 (Figure 2C).
Food intake was more prominently modified by the 7-day
treatment with DSS (Figures 2B,D) than water intake. Two-
Way ANOVA showed that the cumulative intake over the 7-day
treatment period was significantly reduced in response to DSS
[F(1, 12) = 68.7; p < 0.001] but not WAS (Figure 2B), with-
out a significant interaction between the two factors. Repeated
measures ANOVA revealed a significant reduction of the daily
food intake (Figure 2D) during the 7-day treatment period
[F(2.6, 31.2) = 26.8; p < 0.001] with a significant interaction with
DSS, but not WAS [F(2.6, 31.2) = 20.3; p < 0.001]. Post-hoc anal-
ysis disclosed that the daily food intake of DSS-treated mice was
significantly attenuated during days 5–7 (Figure 2D).
WAS PREVENTED THE DSS-INDUCED BEHAVIORAL CHANGES IN THE
OF AND SI TESTS BUT NOT IN THE TST
A 7-day treatment with DSS had a significant influence on behav-
ior in theOF test, which can be interpreted as an anxiogenic effect.
Concomitant WAS exposure prevented the anxiogenic response
to DSS treatment (Figure 3). The total traveling distance in the
OF test (an index of locomotion) was significantly shortened
by DSS [main factor effect: F(1, 62) = 19.3; p < 0.001] and sig-
nificantly prolonged by WAS [main factor effect: F(1,62) = 28;
FIGURE 3 | Effect of a 7-day treatment with DSS and WAS, alone
and in combination, on behavioral parameters of the OF test as
carried out 1 day after the end of the treatment period. (A) Total
traveling distance. Both WAS and DSS had a main factor effect (p <
0.001), but there was no significant interaction between the two
factors. (B) Visits to central area. There was a significant interaction
between WAS and DSS in this parameter (p < 0.05). (C) Percentage
traveling distance in central area, calculated as a percentage of the
total traveling distance. There was a significant interaction between
WAS and DSS in modifying this parameter (p < 0.05). (D) Percentage
time spent in central area, calculated as a percentage of the total time
spent in the OF. There was a significant interaction between WAS and
DSS in modifying this parameter (p < 0.05).The data shown are means
+ s.e.m., n = 14–18 per group; χχχp < 0.001 DSS main factor effect,
δδδp < 0.001 WAS main factor effect, ∗∗p < 0.01, ∗∗∗p < 0.001 vs.
control, §§p < 0.01, §§§p < 0.001 vs. DSS.
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p < 0.001), with no significant interaction between the factors
WAS and DSS. There were significant interactions between DSS
and WAS in their influence on anxiety-related parameters in the
OF test, the number of central area visits [F(1, 62) = 6.1; p =
0.013], percentage traveling distance in the central area [F(1, 62) =
7.0, p = 0.01], and percentage time spent in the central area
[F(1, 62) = 6.3; p = 0.015]. Post-hoc analysis showed that DSS
significantly increased anxiety-like behavior in the absence of
WAS as deduced from a reduction of the percentage time spent in
the central area and the number of central area visits (Figure 3).
In contrast, in the presence of WAS, DSS failed to alter these
anxiety-related behavioral parameters (Figure 3).
In the SI test it was found that DSS treatment reduced SI and
that there was a significant interaction between WAS and DSS
[F(1, 61) = 5.2; p = 0.027]. Post-hoc analysis showed that DSS
significantly reduced the social activity of mice only in the absence
of WAS while, in the presence of WAS, DSS did not affect social
activity (Figure 4).
Unlike in the OF and SI tests, a 7-day treatment with WAS and
DSS, alone and in combination, had little effect on the behav-
ior in the TST (Figure 5). Two-Way ANOVA failed to disclose
any significant effect of DSS or WAS on immobility time, with
no significant interaction. DSS, but not WAS, had a significant
main factor effect on swinging time [F(1, 61) = 9.7; p = 0.003]
and curling time [F(1, 61) = 8.6; p = 0.005], with no significant
interaction between the two factors (Figure 5).
DSS, BUT NOT WAS, INCREASED PLASMA IL-6 AND IL-18
Plasma levels of IL-6 were below detection limits in the control
and WAS groups. The Kruskal-Wallis test revealed a significant
FIGURE 4 | Effect of a 7-day treatment with DSS and WAS, alone and in
combination, on behavior in the SI test as carried out 2 days after the
end of the treatment period. The left (A) and middle (B) panel explain the
procedure of the SI test that consisted of two sessions, the first session
being conducted without a target mouse in the cylindrical container. Panel (C)
presents the results of the SI test as percentage social interaction, calculated
as the percent ratio of the time spent in the interaction zone in the presence
of the target mouse divided by the time spent in the interaction zone in the
absence of the target mouse. There was a significant interaction between
WAS and DSS in modifying social interaction percent (p < 0.05). The data
shown are means + s.e.m., n = 16–17 per group; ∗p < 0.05 vs. control,
§§p < 0.01 vs. DSS.
FIGURE 5 | Effect of a 7-day treatment with DSS and WAS, alone and in
combination, on behavior in the TST as carried out 3 days after the end
of the treatment period. (A) Immobility time. Neither WAS nor DSS had a
main factor effect, nor was there any interaction. (B) Swinging time. There
was a main factor effect of DSS (p < 0.01) but not WAS. (C) Curling time.
There was likewise a main factor effect of DSS (p < 0.01) but not WAS. The
data shown are means + s.e.m., n = 16–17 per group, χχp < 0.01 DSS main
factor effect.
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difference among the treatment groups with regard to IL-6 (H =
23.9; p < 0.001) and IL-18 (H = 19.5; p < 0.001) (Figure 6).
Post-hoc analysis showed that, relative to the control group, the
plasma levels of both IL-6 and IL-18 were significantly increased
in the DSS and WAS+DSS groups while no significant difference
was detected between the control and WAS groups, on the one
hand, and the DSS and WAS+DSS groups, on the other hand
(Figure 6). The plasma levels of IL-10 and IL-12 were below the
detection limits in all treatment groups.
DSS INCREASED PLASMA NPY INDEPENDENTLY OF WAS
The plasma levels of NPY were elevated by a 7-day treatment with
DSS but not WAS (Figure 7A). Two-Way ANOVA revealed a sig-
nificant main factor effect of DSS [F(1, 27) = 65.5; p < 0.001],
with no significant WAS effect and no significant interaction
(Figure 7A).
DSS INCREASED PLASMA CORTICOSTERONE IN THE PRESENCE OF
WAS
A 7-day treatment with DSS and WAS resulted in a signifi-
cant interaction in modifying circulating corticosterone levels
[F(1, 27) = 5.1; p = 0.031]. Post-hoc analysis showed that neither
WAS nor DSS had a significant effect in the absence of the other
factor, while combination of theWAS and DSS treatments led to a
significant increase in the plasma corticosterone levels compared
to the WAS and DSS groups (Figure 7B).
DSS TREATMENT SUPPRESSED THE RELATIVE mRNA EXPRESSION OF
BDNF, NPY, AND MRWHILE WAS SUPPRESSED THE RELATIVE mRNA
EXPRESSION OF CRF IN THE HIPPOCAMPUS
In the hippocampus, DSS treatment blunted the relative mRNA
expression of BDNF [F(1, 25) = 15.4; p < 0.001], NPY [F(1, 25) =
13.8; p = 0.001], and MR [F(1, 25) = 15.4; p < 0.001], with no
FIGURE 6 | Effect of a 7-day treatment with DSS and WAS, alone
and in combination, on plasma levels of IL6 and IL18 as measured
1 day after the end of the treatment period. The IL6 plasma levels
in the control and WAS groups were below detection limit. The data
shown are medians ± quartiles, n = 7–8 per group; ∗p < 0.05,
∗∗p < 0.01 vs. control.
FIGURE 7 | Effect of a 7-day treatment with DSS and WAS, alone and in
combination, on plasma levels of NPY (A) and corticosterone (B) as
measured 1 day after the end of the treatment period. With regard to
plasma NPY, DSS but not WAS had a significant main factor effect (p <
0.001), with no significant interaction. As regards plasma corticosterone,
there was a significant interaction between DSS and WAS (p < 0.05). The
data shown are means + s.e.m., n = 7–8 per group; χχχp < 0.001 DSS main
factor effect, §§p < 0.01 vs. DSS, ###p < 0.001 vs. WAS.
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significant WAS main factor effect and no significant interaction
between the two factors (Table 4). On the other hand, the rela-
tive mRNA expression of CRF was reduced in response to WAS
[F(1, 25) = 4.8; p = 0.035], with no significant DSS main fac-
tor effect and no significant interaction between the two factors
(Table 4). The relative mRNA expression of COX-1, COX-2, and
GR was not significantly changed in the hippocampus (Table 4).
DSS TREATMENT ENHANCED THE RELATIVE mRNA EXPRESSION OF
COX-2, WHILE COMBINED WAS+DSS INCREASED THE RELATIVE
mRNA EXPRESSION OF NPY IN THE HYPOTHALAMUS
In the hypothalamus, DSS treatment but not WAS enhanced the
relative expression of COX-2 mRNA [F(1, 24) = 18; p < 0.001],
without any significant interaction between the two factors
(Table 5). Both DSS and WAS exerted a significant interaction
on the relative expression of NPY mRNA [F(1, 24) = 8.3; p =
0.008]. Post-hoc analysis disclosed that, while WAS and DSS alone
had no significant influence, combined treatment with WAS and
DSS significantly increased hypothalamic NPY gene expression
(Table 5). The relative mRNA expression of COX-1, GR, BDNF,
and CRF was not significantly changed (Table 5).
DSS TREATMENT ANDWAS INTERACT IN MODIFYING THE RELATIVE
mRNA EXPRESSION OF NPY IN THE AMYGDALA
In the amygdala (Table 6), DSS treatment and WAS interacted
with each other in modifying the relative expression of NPY
mRNA [F(1, 25) = 5.1; p = 0.033]. Post-hoc analysis revealed that
WAS alone significantly reduced the relative NPY mRNA expres-
sion in the amygdala, while the combination of WAS and DSS
abolished this effect (Table 6). The relative mRNA expression of
amygdalar COX-1, COX-2, GR, MR, BDNF, and CRF was left
unchanged.
DISCUSSION
Given that stress can be a risk factor for IBD development and
relapse, the aim of this study was to investigate the interaction
Table 4 | Effect of DSS and WAS, alone and in combination, on the relative gene expression of various molecular factors in the hippocampus.
mRNA Control (n = 8) WAS (n = 7) DSS (n = 8) WAS + DSS (n = 6) WAS main factor effect DSS main factor effect Interaction
COX-1 1.0 (0.03) 1.0 (0.04) 0.9 (0.09) 0.9 (0.06) NS NS NS
COX-2 1.0 (0.07) 1.0 (0.05) 0.9 (0.10) 1.0 (0.05) NS NS NS
GR 1.0 (0.04) 1.0 (0.03) 1.0 (0.05) 0.9 (0.07) NS NS NS
MR 1.0 (0.04) 1.0 (0.06) 0.8 (0.06) 0.7 (0.05) NS p < 0.001 NS
BDNF 1.0 (0.06) 1.0 (0.04) 0.8 (0.06) 0.8 (0.06) NS p < 0.001 NS
CRF 1.0 (0.10) 0.7 (0.08) 0.8 (0.10) 0.7 (0.09) p < 0.05 NS NS
NPY 1.0 (0.06) 0.9 (0.06) 0.7 (0.05) 0.8 (0.06) NS p < 0.01 NS
Animals were subjected to a 7-day treatment (days 1–7) with DSS (2% in the drinking water) and WAS (1 h daily), alone or in combination, and sacrificed for the
assay of molecular factors in the microdissected brain on day 8. The data are presented as means (s.e.m.). NS, not significant.
Table 5 | Effect of DSS and WAS, alone and in combination, on the relative gene expression of various molecular factors in the hypothalamus.
mRNA Control (n = 7) WAS (n = 7) DSS (n = 8) WAS + DSS (n = 6) WAS main factor effect DSS main factor effect Interaction
COX-1 1.0 (0.07) 1.3 (0.28) 0.9 (0.07) 1.1 (0.13) NS NS NS
COX-2 1.0 (0.18) 0.8 (0.12) 1.6 (0.13) 1.6 (0.23) NS p < 0.001 NS
GR 1.0 (0.03) 1.0 (0.03) 1.0 (0.04) 1.0 (0.09) NS NS NS
MR 1.0 (0.04) 1.3 (0.20) 0.9 (0.06) 1.0 (0.10) NS NS NS
BDNF 1.0 (0.05) 0.9 (0.10) 0.9 (0.06) 0.9 (0.05) NS NS NS
CRF 1.0 (0.12) 1.5 (0.17) 1.2 (0.10) 1.1 (0.24) NS NS NS
NPY 1.0 (0.11) 1.0 (0.15) 1.6 (0.29) 2.9 (0.31)§§§### p < 0.05 p < 0.001 p < 0.01
Animals were subjected to a 7-day treatment (days 1–7) with DSS (2% in the drinking water) and WAS (1 h daily), alone or in combination, and sacrificed for the
assay of molecular factors in the microdissected brain on day 8. The data are presented as means (s.e.m.). §§§p < 0.001 vs. DSS, ###p < 0.001 vs. WAS. NS, not
significant.
Table 6 | Effect of DSS and WAS, alone and in combination, on the relative gene expression of various molecular factors in the amygdala.
mRNA Control (n = 8) WAS (n = 7) DSS (n = 8) WAS + DSS (n = 6) WAS main factor effect DSS main factor effect Interaction
COX-1 1.0 (0.07) 1.3 (0.28) 0.9 (0.07) 1.1 (0.13) NS NS NS
COX-2 1.0 (0.13) 0.8 (0.08) 1.0 (0.09) 1.1 (0.08) NS NS NS
GR 1.0 (0.03) 1.0 (0.05) 1.1 (0.03) 1.1 (0.08) NS NS NS
MR 1.0 (0.04) 1.3 (0.20) 0.9 (0.06) 1.0 (0.1) NS NS NS
BDNF 1.0 (0.05) 1.0 (0.08) 1.0 (0.05) 1.0 (0.05) NS NS NS
CRF 1.0 (0.09) 0.9 (0.08) 1.3 (0.15) 1.1 (0.12) NS NS NS
NPY 1.0 (0.06) 0.8 (0.04) * 1.0 (0.09) 1.1 (0.06)# NS NS p < 0.05
Animals were subjected to a 7-day treatment (days 1–7) with DSS (2% in the drinking water) and WAS (1 h daily), alone or in combination, and sacrificed for the assay
of molecular factors in the microdissected brain on day 8. The data are presented as means (s.e.m.). *p < 0.05 vs. control, #p < 0.05 vs. WAS. NS, not significant.
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between repeated WAS, a psychological stress model, and DSS-
induced colitis on the severity of colitis and their impact on
emotional-affective behavior and potential neurochemical corre-
lates. The key findings of our work can be summarized as follows.
(i) DSS-induced colitis was associated with several behavioral
changes such as reduced locomotion and enhanced anxiety-like
behavior in the OF test, attenuated social activity in the SI test,
and an altered escape pattern in the TST. (ii) RepeatedWAS alone
failed to induce any sign of colitis and had little influence on
behavior, except that it enhanced locomotion. (iii) The combi-
nation of WAS and DSS treatment prevented the colitis-induced
increase in anxiety-like behavior and decrease in locomotion and
SI without altering the severity of colitis. (iv) DSS-induced col-
itis was associated with an increase in circulating IL6, IL18, and
NPY, an increased expression of COX-2 mRNA in the hypothala-
mus, and a decreased expression of BDNF, NPY, and MR mRNA
in the hippocampus. (v) The beneficial effect of WAS on DSS-
evoked behavioral disturbances was associated with a significant
elevation of circulating corticosterone and a significant rise in the
expression of hypothalamic NPY mRNA.
DSS-INDUCED COLITIS IS ASSOCIATED WITH DISTINCT BEHAVIORAL
ALTERATIONS
DSS-induced colitis was associated with several changes in behav-
ior, these observations extending previous findings (Painsipp
et al., 2011) and attesting to the contention that colonic inflam-
mation impacts on brain function. Thus, DSS-induced colitis
led to a reduction of locomotion in the OF test, an effect that
makes it difficult to interpret the reduced time spent in, and the
reduced number of visits to, the central area of the OF as indica-
tive of an increase in anxiety-like behavior. However, previous
data obtained with another strain of mice indicate that anxiety-
like behavior assessed with the elevated plus maze test can be
enhanced by DSS-induced colitis without a reduction of loco-
motion (Painsipp et al., 2011). It can hence be surmised that
DSS-induced colitis is associated with reduced locomotion and
attenuated curiosity/explorative behavior, which may in part be a
consequence of enhanced anxiety.
In line with the clinical observation that IBD patients experi-
ence social dysfunction (Casati and Toner, 2000; Bernklev et al.,
2005), we found that SI was impaired in mice with colitis. This
behavioral alteration may also be a consequence of the inflamma-
tory process, given that immune challenge and cytokine admin-
istration in rodents lead to social withdrawal (Dantzer et al.,
2008). LPS, a stimulant of the innate immune system, to rats
also causes a dose-dependent social withdrawal which can be
blocked by inactivation of the dorsal vagal complex (Marvel et al.,
2004). Although the decrease in locomotion associated with DSS-
induced colitis may have an influence on the impairment of SI,
the current observations nevertheless indicate that the behavioral
phenotype of DSS-treated mice manifests itself in a syndrome
that comprises attenuated locomotion, attenuated SI, attenuated
curiosity and an apparent increase in anxiety.
DSS-induced colitis was also associated with distinct changes
in escape behavior in the TST which is used to evaluate behavioral
despair in an inescapable situation (Cryan et al., 2005). While
the immobility time, a direct index of despair/depression-like
behavior, was not altered in DSS-treated mice, the time spent
swinging was prolonged and the time spent curling shortened
in these mice. The inability of DSS-induced colitis to modify
the immobility time in the TST is consistent with its inability
to modify despair behavior in the forced swim test (Painsipp
et al., 2011). Although the ethological significance of swinging
and curling is not fully understood, these behavioral parame-
ters can be differentiated in a pharmacological context (Berrocoso
et al., 2013). Thus, opioid receptor agonists decrease immobil-
ity by increasing curling whereas noradrenaline and/or serotonin
reuptake inhibitors decrease immobility by increasing swinging
(Berrocoso et al., 2013). The distinct changes of escape behavior
in DSS-treated mice will guide the future neurochemical analysis
of brain function alterations arising from colonic inflammation.
REPEATED WAS FAILS TO INDUCE COLITIS AND AGGRAVATE COLITIS
SEVERITY PARAMETERS
A review of the literature shows that psychological stress
paradigms have divergent effects on colitis severity. Psychological
stress may increase or decrease the severity of chemically induced
colitis, be devoid of any effect (Reber, 2012), or even induce mild
spontaneous colitis (Reber et al., 2007).
In the current work we assessed the severity of colitis via an
increase in colonic MPO content, colon weight and circulating
IL-6 and IL-18 levels as well as by a decrease in colon length and
body weight. As judged by these criteria, DSS treatment induced
appreciable colitis, whereas WAS was devoid of such an effect.
WAS also failed to interact with DSS in altering the indices of col-
itis severity, with the exception of colon weight which was slightly,
but significantly, enhanced 1 day, but not 4 days, after the end of
the 7-day treatment with WAS+DSS. However, the colitis sever-
ity parameters recorded at the two time points cannot directly be
compared with each other, because the behavioral testing during
days 1–3 after the end of the 7-day treatment period represents
another type of stressor that may have had an effect on the colon.
Despite this limitation we can conclude that repeated WAS does
not induce colitis on its own and that WAS fails, by and large, to
aggravate colitis severity parameters.
REPEATED WAS CAUSES RESILIENCE TO COLITIS-INDUCED
BEHAVIORAL CHANGES IN THE OF AND SI TESTS
There is abundant literature on how stress affects brain func-
tion and behavior, and one of the major aims of this study was
to examine the interaction of colitis, an internal stressor, with
WAS, an external stressor, on the behavioral outcome. Repeated
WAS is a validated model of psychological stress, and it has pre-
viously been reported that WAS and colitis interact with each
other in signaling to, and activation of, the brain (Melgar et al.,
2008; Reichmann et al., 2013). Specifically, DSS-induced coli-
tis alters WAS-induced c-Fos expression in the prefrontal cortex,
hippocampus, and amygdala (Reichmann et al., 2013). In the cur-
rent work we first investigated whether these alterations in the
molecular/cellular stress response manifest themselves in several
behavioral domains: novelty stress in the OF test, social stress in
the SI test, and inescapable stress in the TST.
Exposure of mice to WAS for 7 days affected neither anxiety-
like behavior nor basal plasma corticosterone, which points to
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habituation as previously observed during repeated stress sessions
(Luine et al., 1996; Galea et al., 1997). In addition, the ability
of repeated stress to impact on anxiety may depend on animal
species and strain as well as type of stressor. Thus, the effect of
repeated WAS to enhance anxiety-like behavior as seen in Wistar
rats (Bradesi et al., 2005) cannot be generalized because even
within the same species different strains exhibit different habit-
uation capacities (Dhabhar et al., 1997; Ryabinin et al., 1999).
While we anticipated that repeated WAS would amplify the DSS-
induced behavioral changes, the opposite was observed in the OF
and SI tests: WAS prevented the adverse effect of DSS-induced
colitis on locomotion, anxiety-like behavior and SI. The ability
of WAS to counteract the effect of DSS on emotional behavior,
but not that on ingestion and colitis parameters, also suggests
that the anxiogenic response to DSS is unrelated to any general
malaise.
Beneficial effects of predictable repeated mild stress have been
reported previously (Parihar et al., 2011; Suo et al., 2013). Stress
experiences do not necessarily impair health, and exposure to
a moderate degree of stress that does not exhaust stress-coping
mechanisms can promote future resilience to stress and in this
way prevent the development of psychiatric disorders (Russo
et al., 2012). The relationship between stress exposure and stress
coping can be described as an inverted U shape curve relationship,
wherein both low and high levels of stress impair stress coping,
while intermediate levels of stress promote stress coping mecha-
nisms (Yuen et al., 2009;McEwen andGianaros, 2011; Russo et al.,
2012).
In this context, repeatedWAS for 7 daysmay also be considered
as a model of predictable repeated mild stress, given that expo-
sure to WAS followed a strict scheme in terms of stress duration
and time of the day when the animals were subjected to stress.
To the best of our knowledge, this is the first report that repeated
psychological stress induces resilience to some of the behavioral
manifestations of colitis. It is also important to emphasize that the
beneficial effects of WAS did not extend to all adverse reactions
to colitis. Thus, the DSS-evoked inflammation, anorexia, loss of
body weight, and changes of escape behavior in the TST were
not prevented by repeated WAS. A related observation has been
made in rats subjected to chronic stress, which exhibited resilience
to stress-induced cognitive dysfunction but were still suscepti-
ble to stress-induced weight loss and metabolic changes (Sweis
et al., 2013). Our data are in line with the contention that stress
resilience is a domain-specific rather than a global characteristic
(Sweis et al., 2013).
DSS-INDUCED COLITIS IS ASSOCIATED WITH DISTINCT CHANGES IN
THE CEREBRAL EXPRESSION OF NPY, BDNF AND COX-2
The impact of DSS-induced colitis on behavioral alterations was
analyzed in terms of circulating factors that may communicate
between the gut and brain and cerebral factors that may explain
the behavioral alterations observed. Since IBD is associated with
an increased risk for anxiety and mood disorders (Walker et al.,
2008; Graff et al., 2009), we focused in particular on three mes-
senger molecules that are known for their role in the regulation
of anxiety and mood: NPY, BDNF, and CRF (Holmes et al., 2003;
Martinowich et al., 2007).
As alluded to before, DSS treatment for 7 days increased the
circulating levels of IL-6 and IL-18, which indicates that these
cytokines subserve a long-term signaling role of the inflamed
colon. In contrast, the plasma levels of corticosterone were not
enhanced in DSS-treated mice, which is consistent with other
reports (Reber et al., 2006; Mitrovic et al., 2010) and indicates
that colonic inflammation itself was devoid of a stimulant effect
on the HPA axis. This conclusion is further confirmed by unal-
tered expression of CRF, GR, and MR in the hypothalamus of
DSS-treated mice.
Another circulating factor, NPY, was significantly increased
in DSS-treated mice. This observation is in line with a simi-
lar increase of plasma NPY in mice with TNBS acid-induced
colitis (Baticic et al., 2011). NPY is a neuropeptide that plays
a role at several levels of the gut-brain-gut axis (Holzer et al.,
2012). Although other sources of NPY cannot be excluded, ele-
vated levels of plasma NPY are likely to reflect increased release of
the neuropeptide from sympathetic nerve endings (Bloom et al.,
1988; Zukowska-Grojec, 1995; Renshaw and Hinson, 2001), a
conclusion that is consistent with other data that colitis is asso-
ciated with increased sympathetic activity (Ganguli et al., 2007;
Xia et al., 2011). In addition, NPY has a role in the pathogenesis
of DSS-induced colitis. Thus, NPY gene expression is increased
in enteric ganglia of DSS-treated mice (Chandrasekharan et al.,
2008), and deletion of the NPY gene attenuates the severity
of DSS-induced colitis in mice (Chandrasekharan et al., 2008;
Painsipp et al., 2011). Collectively, the rise of plasma NPY in
colonic inflammation may also arise from an enhanced expres-
sion of the neuropeptide in the enteric nervous system (Holzer
et al., 2012).
In the brain, NPY is one of the most abundant neuropep-
tides, playing a role in many brain functions such as stimulation
of food intake, reduction of anxiety as well as improvement of
stress coping and cognition (Heilig, 2004; Morales-Medina et al.,
2010; Holzer et al., 2012). Local administration of NPY into the
hippocampus causes resilience against experimental models of
chronic mild stress-induced depression and posttraumatic stress
disorder (Luo et al., 2008; Cohen et al., 2012). In the current work
we found that the hippocampal expression of NPY was reduced in
DSS-treated mice. This observation may imply that some of the
behavioral alterations associated with DSS-induced colitis (e.g.,
enhanced anxiety and reduced SI as manifestations of impaired
resilience to novelty and social stress) may be due to a hippocam-
pal deficit of NPY. It is worth mentioning that the expression
of NPY in the hypothalamus tended to increase in mice with
DSS-induced colitis, which is similar to the increase in hypothala-
mic NPY found in mice and rats with TNBS acid-induced colitis
(Ballinger et al., 2001; Baticic et al., 2011). NPY is one of the
most potent orexigenic peptides, and the rise of its hypothalamic
expression in colitis may reflect a counter-regulatory response to
the colitis-evoked anorexia (Ballinger et al., 2001; Holzer et al.,
2012).
Another effect that DSS-induced colitis had in the hypothala-
mus was an increase in the expression of COX-2 mRNA. COX-2
has been involved in LPS- and IL1β-induced anorexia, Asarian
and Langhans (2010), which is also a symptom of IBD, of TNBS
acid-induced colitis in rats and of DSS-induced colitis in mice
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(Gee et al., 1985; Ballinger et al., 2000; DeBoer et al., 2010). DSS-
induced anorexia was also observed in the current work, and
we hypothesize that this effect may be in part explained by the
increase in hypothalamic COX-2 gene expression. In line with this
argument is the observation that WAS neither altered food intake
nor modified hypothalamic COX-2 mRNA.
BDNF has been implicated in both depression and anxiety
(Duman and Monteggia, 2006). In the current work we found
that hippocampal BDNF expression was significantly diminished
in mice with DSS-induced colitis. Our results are in agree-
ment with previous observations that hippocampal BDNFmRNA
expression is lowered in chronic colitis induced by Trichuris muris
(Bercik et al., 2010). This model of colitis is also associated with
increased anxiety (Bercik et al., 2010), which suggests that a
deficit in hippocampal BDNF may be one of the causal factors
in colitis-associated behavioral perturbations.
Since hippocampal MR but not hippocampal GR decreased
in response to DSS treatment, DSS treatment may lead to an
imbalance in MR and GR signaling. A change in the hippocampal
MR/GR ratio has been found in chronic stress-induced depres-
sion and maternally deprived infant rats and may contribute
to HPA axis dysfunction and depression-like behavior (Vázquez
et al., 1996; Lopez et al., 1998).
REPEATED WAS-INDUCED RESILIENCE TO COLITIS-RELATED
BEHAVIORAL DISTURBANCES MAY INVOLVE THE HPA AXIS AND
HYPOTHALAMIC NPY
Given that repeated WAS prevented some of the behavioral per-
turbations in DSS-induced colitis, it was of particular interest
to explore which neuronal and neuroendocrine mechanisms are
specifically altered in WAS+DSS-treated mice and thus could
underlie the resilience effect. One system that may be involved in
the resilience effect of repeatedWAS is theHPA axis. This assump-
tion is based on the observations that combined WAS+DSS
treatment for 7 days led to a significant increase in plasma cor-
ticosterone, while WAS alone or DSS treatment alone for 7 days
failed to modify circulating corticosterone, although a single ses-
sion of WAS activates the HPA axis (Kresse et al., 2001). A
similar finding has been reported by Reber et al. (Reber et al.,
2006) who showed that the diurnal plasma concentration of cor-
ticosterone remained unaffected by DSS treatment or chronic
stress alone, while a combination of the two treatments elevated
circulating corticosterone. This might be explained by synergis-
tic effects of inflammatory mediators and psychological stress
on the HPA axis. Inflammatory mediators are involved in the
regulation of HPA axis activity, and increased proinflammatory
cytokines can stimulate the HPA axis (Turnbull and Rivier, 1995).
For example, IL-6 stimulates ACTH induced release of corticos-
terone from rat primary adrenal gland cells (Salas et al., 1990),
and the cortisol response to ACTH correlates with the blood
IL-6 concentration in healthy humans (Zarkovic et al., 2008).
On the other hand, there is evidence that endogenous corticos-
terone protects from inflammation-induced behavioral changes,
given that behavioral changes due to LPS, IL-1β, and viral infec-
tion are enhanced by adrenalectomy or glucocorticoid antagonists
(Goujon et al., 1995; Johnson et al., 1996; Pezeshki et al., 1996;
Silverman et al., 2007; Wang et al., 2011). Therefore, the increase
in plasma corticosterone elicited by WAS+DSS treatment might
have a role in the resilience effect of WAS against DSS-evoked
anxiety-like behavior and social dysfunction, but this contention
requires pharmacological confirmation.
Plasma NPY is unlikely to be involved in the beneficial effect
of repeated WAS, since repeated WAS does not alter the plasma
levels of NPY as found in the current project and in a pre-
vious study (Kuo et al., 2007), and circulating NPY does not
differ between DSS-treated and WAS+DSS-treated mice. In con-
trast, the expression of NPY mRNA in the hypothalamus was
significantly enhanced by the combined WAS+DSS-treatment
relative to the WAS and DSS treatment alone. The resilience
effect of repeated WAS is thus accompanied by an upregula-
tion of NPY expression in the hypothalamus which attributes
NPY a role in the beneficial effect of repeated WAS on the
DSS-evoked behavioral disturbances. This contention is consis-
tent with the involvement of NPY in promoting stress resilience
(Cohen et al., 2012; Russo et al., 2012; Sweis et al., 2013) and
with the implication of the NPY and Y receptor system in pro-
tecting from behavioral changes induced by peripheral immune
challenge (Painsipp et al., 2008, 2013). In analogy with other data
(Thorsell et al., 2006; Holzer et al., 2012; Sweis et al., 2013) we
postulate that NPY-expressing neurons in the arcuate nucleus
of the hypothalamus are of relevance to the resilience effect of
repeated WAS. Neurons from the arcuate nucleus project to sev-
eral brain regions implicated in the stress resilience effects of
NPY including lateral septum, amygdala, periaqueductal gray
and locus coeruleus (Kask et al., 2002). In addition, hypothala-
mic NPY may induce resilience by interacting with the HPA axis
as circulating glucocorticoids can increase hypothalamic NPY,
while hypothalamic NPY can stimulate the HPA axis and increase
corticosterone release (Krysiak et al., 1999). However, a defi-
nite role of hypothalamic NPY in stress resilience awaits to be
confirmed.
In conclusion, the present results show that experimental coli-
tis leads to a particular range of behavioral alterations, which can
be prevented by repeated WAS, a model of predictable chronic
stress. The DSS-induced behavioral syndrome comprises a reduc-
tion of locomotion and exploration, an apparent increase in
anxiety and a decrease in social activity and is associated with
enhanced expression of COX-2 in the hypothalamus and atten-
uated expression of BDNF, NPY, and MR in the hippocampus.
Taking account of these perturbations adds to the face and con-
struct validity of DSS-induced colitis as a model of IBD and its
association with psychiatric disorders. Although repeated WAS
has little influence on behavior, it gives rise to neuroendocrine
adaptations that prevent the DSS-induced alterations of locomo-
tion, anxiety and SI to becomemanifest. Specifically, the resilience
effect of WAS may involve adjustment of the HPA axis and upreg-
ulation of the NPY system in the hypothalamus. This interaction
between an external and internal stressor sheds new light on
the homeostatic mechanisms that operate under conditions of
intestinal inflammation and psychological stress.
ACKNOWLEDGMENTS
This work was supported by the Austrian Science Fund (FWF
grants P23097-B18, P25912-B23 and W1241-B18). The authors
Frontiers in Behavioral Neuroscience www.frontiersin.org November 2014 | Volume 8 | Article 386 | 13
Hassan et al. Repeated predictable stress causes resilience
thank Margit Eichholzer for the assay of corticosterone, NPY and
myeloperoxidase, and for her help in the PCR.
REFERENCES
Ait-Belgnaoui, A., Colom, A., Braniste, V., Ramalho, L., Marrot, A., Cartier, C., et al.
(2014). Probiotic gut effect prevents the chronic psychological stress-induced
brain activity abnormality in mice. Neurogastroenterol. Motil. 26, 510–520. doi:
10.1111/nmo.12295
Asarian, L., and Langhans, W. (2010). A new look on brain mechanisms of acute ill-
ness anorexia. Physiol. Behav. 100, 464–471. doi: 10.1016/j.physbeh.2010.04.009
Bailey, K. R., and Crawley, J. N. (2009). “Anxiety-Related Behaviors in Mice,” in
Methods of Behavior Analysis in Neuroscience, 2nd Edn., ed J. J. Buccafusco (Boca
Raton, FL: CRC Press), Chapter 5, Available online at: http://www.ncbi.nlm.
nih.gov/books/NBK5221/
Ballinger, A. B., Williams, G., Corder, R., El-Haj, T., and Farthing, M. J. (2001).
Role of hypothalamic neuropeptide Y and orexigenic peptides in anorexia
associated with experimental colitis in the rat. Clin. Sci. 100, 221–229. doi:
10.1042/CS20000211
Ballinger, A., El-Haj, T., Perrett, D., Turvill, J., Obeid, O., Dryden, S., et al. (2000).
The role of medial hypothalamic serotonin in the suppression of feeding in
a rat model of colitis. Gastroenterology 118, 544–553. doi: 10.1016/S0016-
5085(00)70260-5
Baticic, L., Detel, D., Kucic, N., Buljevic, S., Pugel, E. P., and Varljen, J. (2011).
Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a
TNBS-induced model of colitis in mice. J. Cell. Biochem. 112, 3322–3333. doi:
10.1002/jcb.23261
Bercik, P., Park, A. J., Sinclair, D., Khoshdel, A., Lu, J., Huang, X., et al. (2011).
The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal path-
ways for gut-brain communication. Neurogastroenterol. Motil. 23, 1132–1139.
doi: 10.1111/j.1365-2982.2011.01796.x
Bercik, P., Verdu, E. F., Foster, J. A., Macri, J., Potter, M., Huang, X., et al.
(2010). Chronic gastrointestinal inflammation induces anxiety-like behavior
and alters central nervous system biochemistry in mice. Gastroenterology 139,
2102–2112.e1. doi: 10.1053/j.gastro.2010.06.063
Bernklev, T., Jahnsen, J., Lygren, I., Henriksen, M., Vatn, M., and Moum, B. (2005).
Health-related quality of life in patients with inflammatory bowel disease
measured with the short form-36: psychometric assessments and a compar-
ison with general population norms. Inflamm. Bowel Dis. 11, 909–918. doi:
10.1097/01.mib.0000179467.01748.99
Berrocoso, E., Ikeda, K., Sora, I., Uhl, G. R., Sanchez-Blazquez, P., and Mico, J.
A. (2013). Active behaviours produced by antidepressants and opioids in the
mouse tail suspension test. Int. J. Neuropsychopharmacol. 16, 151–162. doi:
10.1017/S1461145711001842
Blazer, D., Hughes, D., and George, L. K. (1987). Stressful life events and the onset
of a generalized anxiety syndrome. Am. J. Psychiatry 144, 1187–1183.
Bloom, S. R., Edwards, A. V., and Jones, C. T. (1988). The adrenal contribution
to the neuroendocrine responses to splanchnic nerve stimulation in conscious
calves. J. Physiol. 397, 513–526.
Bonaz, B., and Taché, Y. (1994). Water-avoidance stress-induced c-fos expression
in the rat brain and stimulation of fecal output: role of corticotropin-releasing
factor. Brain Res. 641, 21–28. doi: 10.1016/0006-8993(94)91810-4
Bradesi, S., Schwetz, I., Ennes, H. S., Lamy, C. M., Ohning, G., Fanselow, M., et al.
(2005). Repeated exposure to water avoidance stress in rats: a new model for
sustained visceral hyperalgesia. Am. J. Physiol. Gastrointest. Liver Physiol. 289,
G42–G53. doi: 10.1152/ajpgi.00500.2004
Brunner, S. M., Farzi, A., Locker, F., Holub, B. S., Drexel, M., Reichmann, F., et al.
(2014). GAL3 receptor KO mice exhibit an anxiety-like phenotype. Proc. Natl.
Acad. Sci. U.S.A. 111, 7138–7143. doi: 10.1073/pnas.1318066111
Casati, J., and Toner, B. (2000). Psychosocial aspects of inflammatory bowel disease.
Biomed. Pharmacother. 54, 388–393. doi: 10.1016/S0753-3322(01)80006-8
Chandrasekharan, B., Bala, V., Kolachala, V. L., Vijay-Kumar, M., Jones,
D., Gewirtz, A. T., et al. (2008). Targeted deletion of neuropeptide Y
(NPY) modulates experimental colitis. PLoS ONE 3:e3304. doi: 10.1371/jour-
nal.pone.0003304
Cohen, H., Liu, T., Kozlovsky, N., Kaplan, Z., Zohar, J., and Mathé, A. A. (2012).
The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience
to stress exposure in an animal model of post-traumatic stress disorder.
Neuropsychopharmacology 37, 350–363. doi: 10.1038/npp.2011.230
Cosnes, J., Gower–Rousseau, C., Seksik, P., and Cortot, A. (2011). Epidemiology
and natural history of inflammatory bowel diseases. Gastroenterology 140,
1785.e4–1794.e4. doi: 10.1053/j.gastro.2011.01.055
Cover, P. O., Slater, D., and Buckingham, J. C. (2001). Expression of cyclooxyge-
nase enzymes in rat hypothalamo-pituitary-adrenal axis: effects of endotoxin
and glucocorticoids. Endocrine 16, 123–131. doi: 10.1385/ENDO:16:2:123
Cryan, J. F., Mombereau, C., and Vassout, A. (2005). The tail suspension test
as a model for assessing antidepressant activity: review of pharmacologi-
cal and genetic studies in mice. Neurosci. Biobehav. Rev. 29, 571–625. doi:
10.1016/j.neubiorev.2005.03.009
Dantzer, R., O’Connor, J. C., Freund, G. G., Johnson, R. W., and Kelley, K. W.
(2008). From inflammation to sickness and depression: when the immune
system subjugates the brain. Nat. Rev. Neurosci. 9, 46–56. doi: 10.1038/nrn2297
DeBoer, M. D., Li, Y., and Cohn, S. (2010). Colitis causes delay in puberty in female
mice out of proportion to changes in leptin and corticosterone. J. Gastroenterol.
45, 277–284. doi: 10.1007/s00535-009-0192-x
de Theije, C. G., Koelink, P. J., Korte-Bouws, G. A., Lopes da Silva, S.,
Korte, S. M., Olivier, B., et al. (2014). Intestinal inflammation in a murine
model of autism spectrum disorders. Brain Behav. Immun. 37, 240–247. doi:
10.1016/j.bbi.2013.12.004
Dhabhar, F. S., McEwen, B. S., and Spencer, R. L. (1997). Adaptation to pro-
longed or repeated stress–comparison between rat strains showing intrinsic
differences in reactivity to acute stress. Neuroendocrinology 65, 360–368. doi:
10.1159/000127196
Duman, R. S., and Monteggia, L. M. (2006). A neurotrophic model for
stress-related mood disorders. Biol. Psychiatry 59, 1116–1127. doi:
10.1016/j.biopsych.2006.02.013
Ferenczi, S., Zelei, E., Pinter, B., Szoke, Z., and Kovacs, K. J. (2010). Differential
regulation of hypothalamic neuropeptide Y hnRNA and mRNA during psy-
chological stress and insulin-induced hypoglycemia. Mol. Cell. Endocrinol. 321,
138–145. doi: 10.1016/j.mce.2010.02.036
Galea, L. A., McEwen, B. S., Tanapat, P., Deak, T., Spencer, R. L., and Dhabhar,
F. S. (1997). Sex differences in dendritic atrophy of CA3 pyramidal neu-
rons in response to chronic restraint stress. Neuroscience 81, 689–697. doi:
10.1016/S0306-4522(97)00233-9
Ganguli, S., Kamath, M., Redmond, K., Chen, Y., Irvine, E., Collins, S., et al.
(2007). A comparison of autonomic function in patients with inflammatory
bowel disease and in healthy controls. Neurogastroenterol. Motil. 19, 961–967.
doi: 10.1111/j.1365-2982.2007.00987.x
Gee, M. I., Grace, M. G., Wensel, R. H., Sherbaniuk, R., and Thomson, A. B. (1985).
Protein-energy malnutrition in gastroenterology outpatients: increased risk in
Crohn’s disease. J. Am. Diet. Assoc. 85, 1466–1474.
Goujon, E., Parnet, P., Aubert, A., Goodall, G., and Dantzer, R. (1995).
Corticosterone regulates behavioral effects of lipopolysaccharide and
interleukin-1 beta in mice. Am. J. Physiol. 269, R154–R159.
Graff, L. A., Walker, J. R., and Bernstein, C. N. (2009). Depression and anxi-
ety in inflammatory bowel disease: a review of comorbidity and management.
Inflamm. Bowel Dis. 15, 1105–1118. doi: 10.1002/ibd.20873
Gregus, A., Wintink, A. J., Davis, A. C., and Kalynchuk, L. E. (2005). Effect
of repeated corticosterone injections and restraint stress on anxiety and
depression-like behavior in male rats. Behav. Brain Res. 156, 105–114. doi:
10.1016/j.bbr.2004.05.013
Guthrie, E., Jackson, J., Shaffer, J., Thompson, D., Tomenson, B., and Creed, F.
(2002). Psychological disorder and severity of inflammatory bowel disease pre-
dict health-related quality of life in ulcerative colitis and Crohn’s disease. Am. J.
Gastroenterol. 97, 1994–1999. doi: 10.1111/j.1572-0241.2002.05842.x
Heilig, M. (2004). The NPY system in stress, anxiety and depression.Neuropeptides
38, 213–224. doi: 10.1016/j.npep.2004.05.002
Hellemans, J., Mortier, G., De Paepe, A., Speleman, F., and Vandesompele, J. (2007).
qBase relative quantification framework and software for management and
automated analysis of real-time quantitative PCR data. Genome Biol. 8:R19. doi:
10.1186/gb-2007-8-2-r19
Holmes, A., Heilig, M., Rupniak, N. M., Steckler, T., and Griebel, G. (2003).
Neuropeptide systems as novel therapeutic targets for depression and anx-
iety disorders. Trends Pharmacol. Sci. 24, 580–588. doi: 10.1016/j.tips.2003.
09.011
Holzer, P., Reichmann, F., and Farzi, A. (2012). Neuropeptide Y, peptide YY and
pancreatic polypeptide in the gut–brain axis. Neuropeptides 46, 261–274. doi:
10.1016/j.npep.2012.08.005
Frontiers in Behavioral Neuroscience www.frontiersin.org November 2014 | Volume 8 | Article 386 | 14
Hassan et al. Repeated predictable stress causes resilience
Johnson, R. W., Propes, M. J., and Shavit, Y. (1996). Corticosterone modulates
behavioral and metabolic effects of lipopolysaccharide. Am. J. Physiol. 270,
R192–R198.
Kask, A., Harro, J., von Hörsten, S., Redrobe, J. P., Dumont, Y., and Quirion,
R. (2002). The neurocircuitry and receptor subtypes mediating anxiolytic-
like effects of neuropeptide Y. Neurosci. Biobehav. Rev. 26, 259–283. doi:
10.1016/S0149-7634(01)00066-5
Kendler, K. S., Hettema, J. M., Butera, F., Gardner, C. O., and Prescott, C. A.
(2003). Life event dimensions of loss, humiliation, entrapment, and danger in
the prediction of onsets of major depression and generalized anxiety. Arch. Gen.
Psychiatry 60, 789–796. doi: 10.1001/archpsyc.60.8.789
Krawisz, J. E., Sharon, P., and Stenson, W. F. (1984). Quantitative assay
for acute intestinal inflammation based on myeloperoxidase activity.
Assessment of inflammation in rat and hamster models. Gastroenterology 87,
1344–1350.
Kresse, A. E., Million, M., Saperas, E., and Tache, Y. (2001). Colitis induces
CRF expression in hypothalamic magnocellular neurons and blunts CRF gene
response to stress in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 281,
G1203–G1213.
Krysiak, R., Obuchowicz, E., and Herman, Z. S. (1999). Interactions between the
neuropeptide Y system and the hypothalamic-pituitary-adrenal axis. Eur. J.
Endocrinol. 140, 130–136. doi: 10.1530/eje.0.1400130
Kuo, L. E., Kitlinska, J. B., Tilan, J. U., Li, L., Baker, S. B., Johnson, M. D., et al.
(2007). Neuropeptide Y acts directly in the periphery on fat tissue and mediates
stress-induced obesity and metabolic syndrome. Nat. Med. 13, 803–811. doi:
10.1038/nm1611
Lopez, J. F., Chalmers, D. T., Little, K. Y., and Watson, S. J. (1998). A.E. Bennett
Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorti-
coid receptor in rat and human hippocampus: implications for the neurobiol-
ogy of depression. Biol. Psychiatry 43, 547–573.
Lugarini, F., Hrupka, B. J., Schwartz, G. J., Plata-Salaman, C. R., and Langhans, W.
(2002). A role for cyclooxygenase-2 in lipopolysaccharide-induced anorexia in
rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R862–R868.
Luine, V., Martinez, C., Villegas, M., Magarinos, A. M., and McEwen, B. S. (1996).
Restraint stress reversibly enhances spatial memory performance. Physiol.
Behav. 59, 27–32. doi: 10.1016/0031-9384(95)02016-0
Luo, D. D., An, S. C., and Zhang, X. (2008). Involvement of hippocampal serotonin
and neuropeptide Y in depression induced by chronic unpredicted mild stress.
Brain Res. Bull. 77, 8–12. doi: 10.1016/j.brainresbull.2008.05.010
Martinowich, K., Manji, H., and Lu, B. (2007). New insights into BDNF function
in depression and anxiety. Nat. Neurosci. 10, 1089–1093. doi: 10.1038/nn1971
Marvel, F. A., Chen, C., Badr, N., Gaykema, R., and Goehler, L. E. (2004). Reversible
inactivation of the dorsal vagal complex blocks lipopolysaccharide-induced
social withdrawal and c-Fos expression in central autonomic nuclei. Brain
Behav. Immun. 18, 123–134. doi: 10.1016/j.bbi.2003.09.004
Mawdsley, J. E., and Rampton, D. S. (2006). The role of psychological stress
in inflammatory bowel disease. Neuroimmunomodulation 13, 327–336. doi:
10.1159/000104861
McEwen, B. S., and Gianaros, P. J. (2011). Stress- and allostasis-induced brain plas-
ticity. Annu. Rev. Med. 62, 431–445. doi: 10.1146/annurev-med-052209-100430
Melgar, S., Engström, K., Jägervall, A., andMartinez, V. (2008). Psychological stress
reactivates dextran sulfate sodium-induced chronic colitis in mice. Stress 11,
348–362. doi: 10.1080/10253890701820166
Milde, A. M., and Murison, R. (2002). A study of the effects of restraint stress on
colitis induced by dextran sulphate sodium in singly housed rats. Integr. Physiol.
Behav. Sci. 37, 140–150. doi: 10.1007/BF02688826
Mitrovic, M., Shahbazian, A., Bock, E., Pabst, M. A., and Holzer, P. (2010). Chemo-
nociceptive signalling from the colon is enhanced by mild colitis and blocked by
inhibition of transient receptor potential ankyrin 1 channels. Br. J. Pharmacol.
160, 1430–1442. doi: 10.1111/j.1476-5381.2010.00794.x
Morales-Medina, J. C., Dumont, Y., and Quirion, R. (2010). A possible role
of neuropeptide Y in depression and stress. Brain Res. 1314, 194–205. doi:
10.1016/j.brainres.2009.09.077
Nordin, K., Påhlman, L., Larsson, K., Sundberg-Hjelm, M., and Lööf, L. (2002).
Health-related quality of life and psychological distress in a population-
based sample of Swedish patients with inflammatory bowel disease. Scand. J.
Gastroenterol. 37, 450–457. doi: 10.1080/003655202317316097
Painsipp, E., Herzog, H., and Holzer, P. (2008). Implication of neuropeptide-Y
Y2 receptors in the effects of immune stress on emotional, locomotor
and social behavior of mice. Neuropharmacology 55, 117–126. doi:
10.1016/j.neuropharm.2008.05.004
Painsipp, E., Herzog, H., Sperk, G., and Holzer, P. (2011). Sex-dependent con-
trol of murine emotional-affective behaviour in health and colitis by peptide
YY and neuropeptide Y. Br. J. Pharmacol. 163, 1302–1314. doi: 10.1111/j.1476-
5381.2011.01326.x
Painsipp, E., Kofer, M. J., Farzi, A., Dischinger, U. S., Sinner, F., Herzog, H.,
et al. (2013). Neuropeptide Y and peptide YY protect from weight loss caused
by Bacille Calmette-Guerin in mice. Br. J. Pharmacol. 170, 1014–1026. doi:
10.1111/bph.12354
Parihar, V. K., Hattiangady, B., Kuruba, R., Shuai, B., and Shetty, A. K. (2011).
Predictable chronic mild stress improves mood, hippocampal neurogenesis and
memory. Mol. Psychiatry 16, 171–183. doi: 10.1038/mp.2009.130
Persoons, P., Vermeire, S., Demyttenaere, K., Fischler, B., Vandenberghe, J., Van
Oudenhove, L., et al. (2005). The impact of major depressive disorder on the
short-and long-term outcome of Crohn’s disease treatment with infliximab.
Aliment. Pharmacol. Ther. 22, 101–110. doi: 10.1111/j.1365-2036.2005.02535.x
Pezeshki, G., Pohl, T., and Schobitz, B. (1996). Corticosterone controls interleukin-
1 beta expression and sickness behavior in the rat. J. Neuroendocrinol. 8,
129–135. doi: 10.1111/j.1365-2826.1996.tb00833.x
Reber, S. (2012). Stress and animal models of inflammatory bowel disease—
an update on the role of the hypothalamo–pituitary–adrenal axis.
Psychoneuroendocrinology 37, 1–19. doi: 10.1016/j.psyneuen.2011.05.014
Reber, S., Birkeneder, L., Veenema, A., Obermeier, F., Falk, W., Straub, R.,
et al. (2007). Adrenal insufficiency and colonic inflammation after a novel
chronic psycho-social stress paradigm in mice: implications and mechanisms.
Endocrinology 148, 670–682. doi: 10.1210/en.2006-0983
Reber, S., Obermeier, F., Straub, R. H., Falk, W., and Neumann, I. D. (2006).
Chronic intermittent psychosocial stress (social defeat/overcrowding) in mice
increases the severity of an acute DSS-induced colitis and impairs regeneration.
Endocrinology 147, 4968–4976. doi: 10.1210/en.2006-0347
Reichmann, F., Painsipp, E., and Holzer, P. (2013). Environmental enrichment
and gut inflammation modify stress-induced c-Fos expression in the mouse
corticolimbic system. PLoS ONE 8:e54811. doi: 10.1371/journal.pone.0054811
Renshaw, D., and Hinson, J. (2001). Neuropeptide Y and the adrenal gland: a
review. Peptides 22, 429–438. doi: 10.1016/S0196-9781(01)00353-9
Russo, S. J., Murrough, J. W., Han, M., Charney, D. S., and Nestler, E. J. (2012).
Neurobiology of resilience. Nat. Neurosci. 15, 1475–1484. doi: 10.1038/nn.3234
Ryabinin, A. E., Wang, Y. M., and Finn, D. A. (1999). Different levels of Fos
immunoreactivity after repeated handling and injection stress in two inbred
strains of mice. Pharmacol. Biochem. Behav. 63, 143–151. doi: 10.1016/S0091-
3057(98)00239-1
Salas, M., Evans, S., Levell, M., and Whicher, J. (1990). Interleukin-6 and ACTH
act synergistically to stimulate the release of corticosterone from adrenal gland
cells. Clin. Exp. Immunol. 79, 470–473.
Schmittgen, T. D., and Livak, K. J. (2008). Analyzing real-time PCR data by the
comparative CT method.Nat. Protoc. 3, 1101–1108. doi: 10.1038/nprot.2008.73
Silverman, M. N., Macdougall, M. G., Hu, F., Pace, T. W., Raison, C. L., and Miller,
A. H. (2007). Endogenous glucocorticoids protect against TNF-alpha-induced
increases in anxiety-like behavior in virally infected mice. Mol. Psychiatry 12,
408–417. doi: 10.1038/sj.mp.4001921
Solomon, L., Mansor, S., Mallon, P., Donnelly, E., Hoper, M., Loughrey, M., et al.
(2010). The dextran sulphate sodium (DSS) model of colitis: an overview. Mol.
Med. 19, 235–239. doi: 10.2119/molmed.2011.00069
Spandidos, A., Wang, X., Wang, H., and Seed, B. (2010). PrimerBank: a resource
of human and mouse PCR primer pairs for gene expression detection and
quantification. Nucleic Acids Res. 38, D792–D799. doi: 10.1093/nar/gkp1005
Suo, L., Zhao, L., Si, J., Liu, J., Zhu, W., Chai, B., et al. (2013). Predictable
chronic mild stress in adolescence increases resilience in adulthood.
Neuropsychopharmacology 38, 1387–1400. doi: 10.1038/npp.2013.67
Sweis, B. M., Veverka, K. K., Dhillon, E. S., Urban, J. H., and Lucas, L. R. (2013).
Individual differences in the effects of chronic stress on memory: behavioral
and neurochemical correlates of resiliency. Neuroscience 246, 142–159. doi:
10.1016/j.neuroscience.2013.04.052
Tabuchi, K., Blundell, J., Etherton, M. R., Hammer, R. E., Liu, X., Powell, C. M.,
et al. (2007). A neuroligin-3 mutation implicated in autism increases inhibitory
synaptic transmission in mice. Science 318, 71–76. doi: 10.1126/science.1146221
Thorsell, A., Slawecki, C. J., El Khoury, A., Mathe, A. A., and Ehlers, C. L.
(2006). The effects of social isolation on neuropeptide Y levels, exploratory and
Frontiers in Behavioral Neuroscience www.frontiersin.org November 2014 | Volume 8 | Article 386 | 15
Hassan et al. Repeated predictable stress causes resilience
anxiety-related behaviors in rats. Pharmacol. Biochem. Behav. 83, 28–34. doi:
10.1016/j.pbb.2005.12.005
Turnbull, A. V., and Rivier, C. (1995). Regulation of the HPA axis by
cytokines. Brain Behav. Immun. 9, 253–275. doi: 10.1006/brbi.19
95.1026
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A.,
et al. (2002). Accurate normalization of real-time quantitative RT-PCR data
by geometric averaging of multiple internal control genes. Genome Biol. 3,
RESEARCH0034. doi: 10.1186/gb-2002-3-7-research0034
Vázquez, D. M., Van Oers, H., Levine, S., and Akil, H. (1996). Regulation of glu-
cocorticoid and mineralocorticoid receptor mRNAs in the hippocampus of
the maternally deprived infant rat. Brain Res. 731, 79–90. doi: 10.1016/0006-
8993(96)00465-9
Vowinkel, T., Kalogeris, T. J., Mori, M., Krieglstein, C. F., and Granger,
D. N. (2004). Impact of dextran sulfate sodium load on the severity
of inflammation in experimental colitis. Dig. Dis. Sci. 49, 556–564. doi:
10.1023/B:DDAS.0000026298.72088.f7
Walker, J. R., Ediger, J. P., Graff, L. A., Greenfeld, J. M., Clara, I., Lix, L.,
et al. (2008). The Manitoba IBD cohort study: a population-based study
of the prevalence of lifetime and 12-month anxiety and mood disor-
ders. Am. J. Gastroenterol. 103, 1989–1997. doi: 10.1111/j.1572-0241.2008.
01980.x
Wang, D., Lin, W., Pan, Y., Kuang, X., Qi, X., and Sun, H. (2011). Chronic block-
ade of glucocorticoid receptors by RU486 enhances lipopolysaccharide-induced
depressive-like behaviour and cytokine production in rats. Brain Behav. Immun.
25, 706–714. doi: 10.1016/j.bbi.2011.01.011
Xia, C., Colomb, D., Akbarali, H., and Qiao, L. (2011). Prolonged sympathetic
innervation of sensory neurons in rat thoracolumbar dorsal root ganglia during
chronic colitis. Neurogastroenterol. Motil. 23, 801–e339. doi: 10.1111/j.1365-
2982.2011.01728.x
Ye, J., Coulouris, G., Zaretskaya, I., Cutcutache, I., Rozen, S., and Madden, T. L.
(2012). Primer-BLAST: a tool to design target-specific primers for polymerase
chain reaction. BMC Bioinformatics 13:134. doi: 10.1186/1471-2105-
13-134
Yuen, E. Y., Liu, W., Karatsoreos, I. N., Feng, J., McEwen, B. S., and Yan, Z. (2009).
Acute stress enhances glutamatergic transmission in prefrontal cortex and facil-
itates working memory. Proc. Natl. Acad. Sci. U.S.A. 106, 14075–14079. doi:
10.1073/pnas.0906791106
Zarkovic, M., Ignjatovic, S., Dajak, M., Ciric, J., Beleslin, B., Savic, S., et al.
(2008). Cortisol response to ACTH stimulation correlates with blood inter-
leukin 6 concentration in healthy humans. Eur. J. Endocrinol. 159, 649–652. doi:
10.1530/EJE-08-0544
Zukowska-Grojec, Z. (1995). Neuropeptide Y. A novel sympathetic stress
hormone and more. Ann. N.Y. Acad. Sci. 771, 219–233. doi: 10.1111/j.1749-
6632.1995.tb44683.x
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 16 July 2014; accepted: 17 October 2014; published online: 06 November
2014.
Citation: Hassan AM, Jain P, Reichmann F, Mayerhofer R, Farzi A, Schuligoi R
and Holzer P (2014) Repeated predictable stress causes resilience against colitis-
induced behavioral changes in mice. Front. Behav. Neurosci. 8:386. doi: 10.3389/fnbeh.
2014.00386
This article was submitted to the journal Frontiers in Behavioral Neuroscience.
Copyright © 2014 Hassan, Jain, Reichmann, Mayerhofer, Farzi, Schuligoi and
Holzer. This is an open-access article distributed under the terms of the Creative
Commons Attribution License (CC BY). The use, distribution or reproduction in other
forums is permitted, provided the original author(s) or licensor are credited and that
the original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply with
these terms.
Frontiers in Behavioral Neuroscience www.frontiersin.org November 2014 | Volume 8 | Article 386 | 16
